Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Apr 9;84(3):606–611. doi: 10.1016/j.ijrobp.2012.01.039

Table 1b.

Tumor characteristics (N=101, 1 patient with bilateral breast cancer)

Tumor dimension (cm)
Median 9 mm
Range 1.2mm –19mm
<1 cm 56 (55%)
>1cm and <2 cm 45 (45%)
Histology
Invasive ductal 74 (75%)
Invasive lobular 16 (16%)
Invasive tubular 6 (6%)
Invasive Ductal+Lobular 1 (1%)
Invasive colloid 2 (2%)
N/A* 1
Nodal Status
N0 101** (100%)
pN0 at sentinel node or axillary dissection 96 (96%)
No nodal assessment because of <5mm primary 5 (5%)
ER+ 99 (99%)
ER− 1 (1%)
PR+ 65 (65%)
PR− 35 (35%)
HER2 (+)
Yes 5** (5%)
No 93 (95%)
N/A 2
Ki67 (available in 78/100)
Proliferation <14% 68 (87%)
Proliferation >14% 9 (11%)
*

insufficient tissue to perform the test

**

one patient with bilateral breast cancer

***

1pt received trastuzumab